In conclusion, YAP/TAZ has been demonstrated to be a therapeutic target for atherosclerosis and is implicated in the formation of atherosclerosis through regulation of endothelial cells and macrophage (Figure 5). The gene discussed is YAP1; the disease is atherosclerosis.